Back

RE: A synthetic peptide from transforming growth factor-β1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovascular Research, Volume 81, Issue 3, 15 February 2009, Pages 601–609. Javier Díez, https://doi.org/10.1093/cvr/cvn315

Cardiovascular Research

5 August 2020
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Association of the exerkines apelin and irisin with myocardial fibrosis and cardiac dysfunction in early stages of hypertensive heart failure
22 May 2023
thumbnail
Congress Presentation
Role of platelet GARP in TGFB activation
27 August 2021
thumbnail
Congress Presentation
Protein tyrosine phosphatase sigma and zeta1 regulate cardiac fibroblast contractile function through TGF-beta dependent and independent pathways
26 August 2023
thumbnail
Congress Presentation
Pirfenidone added to standard therapy for myocardial infarction further reduces left ventricular fibrosis: a preclinical study
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources